Literature DB >> 7960993

Realization and verification of three-dimensional conformal radiotherapy with modulated fields.

T Bortfeld1, A L Boyer, W Schlegel, D L Kahler, T J Waldron.   

Abstract

PURPOSE: We describe the experimental demonstration of the delivery of a three-dimensional conformal radiotherapy dose distribution using in-field modulation of nine fixed-gantry fields. METHODS AND MATERIALS: Two-dimensional in-field modulation profiles, varying from field to field, were realized by quasi-dynamic multileaf collimation using the prototype of a commercially available multileaf collimator installed on a medical linear accelerator. The profiles were calculated to deliver an optimal dose distribution for a patient with a prostate carcinoma. The target volume surface was invaginated and bifurcated. The calculated dose distribution was delivered to a homogeneous polystyrene phantom consisting of 1 cm thick slices that were cut to match the patient's outer contour. Seven therapy verification films were placed between the phantom slices.
RESULTS: Analysis of the films revealed a degree of conformation of the high-dose region to the target shape that would not be possible with unmodulated conformal therapy. However, small observed spatial displacements of the dose distribution confirm the need for very accurate positioning.
CONCLUSIONS: It is feasible to deliver clinically relevant, three-dimensional dose distributions that conform to invaginated and bifurcated target volumes using fields modulated by multileaf collimators.

Entities:  

Mesh:

Year:  1994        PMID: 7960993     DOI: 10.1016/0360-3016(94)90366-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  [Inverse radiotherapy planning].

Authors:  W Schlegel; P Kneschaurek
Journal:  Strahlenther Onkol       Date:  1999-05       Impact factor: 3.621

2.  Inverse radiotherapy planning for a concave-convex PTV in cervical and upper mediastinal regions. Simulation of radiotherapy using an Alderson-RANDO phantom. Planning target volume.

Authors:  O Esik; T Bortfeld; R Bendl; G Németh; W Schlegel
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

Review 3.  Update on treatment advances in combined-modality therapy for anal and rectal carcinomas.

Authors:  Jeffrey Meyer; Glen Balch; Christopher Willett; Brian Czito
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

4.  Particle radiation therapy for gastrointestinal malignancies.

Authors:  Jeffrey J Meyer; Brian G Czito; Christopher G Willett
Journal:  Gastrointest Cancer Res       Date:  2007

5.  Consistency and reproducibility of the VMAT plan delivery using three independent validation methods.

Authors:  Varatharaj Chandraraj; Sotirios Stathakis; Ravikumar Manickam; Carlos Esquivel; Sanjay S Supe; Nikos Papanikolaou
Journal:  J Appl Clin Med Phys       Date:  2010-11-16       Impact factor: 2.102

6.  Evaluation of a commercial DIR platform for contour propagation in prostate cancer patients treated with IMRT/VMAT.

Authors:  Jacob E Hammers; Sara Pirozzi; Daniel Lindsay; Orit Kaidar-Person; Xianming Tan; Ronald C Chen; Shiva K Das; Panayiotis Mavroidis
Journal:  J Appl Clin Med Phys       Date:  2020-02       Impact factor: 2.102

7.  Dosimetric effect of limited aperture multileaf collimator on VMAT plan quality: A study of prostate and head-and-neck cancers.

Authors:  Ghulam Murtaza; Shahid Mehmood; Shahid Rasul; Imran Murtaza; Ehsan Ullah Khan
Journal:  Rep Pract Oncol Radiother       Date:  2018-03-21

Review 8.  Medical physics challenges in clinical MR-guided radiotherapy.

Authors:  Christopher Kurz; Giulia Buizza; Guillaume Landry; Florian Kamp; Moritz Rabe; Chiara Paganelli; Guido Baroni; Michael Reiner; Paul J Keall; Cornelis A T van den Berg; Marco Riboldi
Journal:  Radiat Oncol       Date:  2020-05-05       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.